Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Liberty Global Ltd. Director's Dealing 2023

Apr 27, 2023

31176_dirs_2023-04-27_e3c2728c-8988-4292-b506-29d328bedee0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Liberty Global plc (LBTY)
CIK: 0001570585
Period of Report: 2023-04-25

Reporting Person: MALONE JOHN C (Director, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-04-25 Share Option A (right to buy) $32.81 D 30259 Disposed 2023-05-01 Class A Ordinary Shares (30259.0) Direct
2023-04-25 Share Option A (right to buy) $32.81 A 30259 Acquired 2026-05-01 Class A Ordinary Shares (30259.0) Direct
2023-04-25 Share Option A (right to buy) $35.69 D 32473 Disposed 2024-05-01 Class A Ordinary Shares (32473.0) Direct
2023-04-25 Share Option A (right to buy) $35.69 A 32473 Acquired 2027-05-01 Class A Ordinary Shares (32473.0) Direct
2023-04-25 Share Option C (right to buy) $31.65 D 60518 Disposed 2023-05-01 Class C Ordinary Shares (60518.0) Direct
2023-04-25 Share Option C (right to buy) $31.65 A 60518 Acquired 2026-05-01 Class C Ordinary Shares (60518.0) Direct
2023-04-25 Share Option C (right to buy) $34.8 D 64946 Disposed 2024-05-01 Class C Ordinary Shares (64946.0) Direct
2023-04-25 Share Option C (right to buy) $34.8 A 64946 Acquired 2027-05-01 Class C Ordinary Shares (64946.0) Direct
2023-04-25 Share Option C (right to buy) $28.94 D 129974 Disposed 2025-05-01 Class C Ordinary Shares (129974.0) Direct
2023-04-25 Share Option C (right to buy) $28.94 A 129974 Acquired 2028-05-01 Class C Ordinary Shares (129974.0) Direct

Footnotes

F1: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.